KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash from Investing Activities (2016 - 2025)

Edwards Lifesciences has reported Cash from Investing Activities over the past 17 years, most recently at -$198.3 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$198.3 million for Q4 2025, up 65.61% from a year ago — trailing twelve months through Dec 2025 was -$712.9 million (down 130.82% YoY), and the annual figure for FY2025 was -$712.9 million, down 130.82%.
  • Cash from Investing Activities for Q4 2025 was -$198.3 million at Edwards Lifesciences, up from -$427.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for EW hit a ceiling of $2.7 billion in Q3 2024 and a floor of -$965.9 million in Q4 2021.
  • Median Cash from Investing Activities over the past 5 years was $7.3 million (2023), compared with a mean of $15.2 million.
  • Peak annual rise in Cash from Investing Activities hit 12520.0% in 2024, while the deepest fall reached 4190.07% in 2024.
  • Edwards Lifesciences' Cash from Investing Activities stood at -$965.9 million in 2021, then skyrocketed by 109.8% to $94.7 million in 2022, then plummeted by 85.11% to $14.1 million in 2023, then tumbled by 4190.07% to -$576.7 million in 2024, then soared by 65.61% to -$198.3 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$198.3 million (Q4 2025), -$427.8 million (Q3 2025), and -$172.1 million (Q2 2025) per Business Quant data.